» Articles » PMID: 22811709

Chemical Methods to Induce Beta-cell Proliferation

Overview
Publisher Wiley
Specialty Endocrinology
Date 2012 Jul 20
PMID 22811709
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic beta-cell regeneration, for example, by inducing proliferation, remains an important goal in developing effective treatments for diabetes. However, beta cells have mainly been considered quiescent. This "static" view has recently been challenged by observations of relevant physiological conditions in which metabolic stress is compensated by an increase in beta-cell mass. Understanding the molecular mechanisms underlining these process could open the possibility of developing novel small molecules to increase beta-cell mass. Several cellular cell-cycle and signaling proteins provide attractive targets for high throughput screening, and recent advances in cell culture have enabled phenotypic screening for small molecule-induced beta-cell proliferation. We present here an overview of the current trends involving small-molecule approaches to induce beta-cell regeneration by proliferation.

Citing Articles

Advanced therapy to cure diabetes: mission impossible is now possible?.

Rohban R, Martins C, Esni F Front Cell Dev Biol. 2024; 12:1484859.

PMID: 39629270 PMC: 11611888. DOI: 10.3389/fcell.2024.1484859.


BefA, a microbiota-secreted membrane disrupter, disseminates to the pancreas and increases β cell mass.

Hill J, Massaquoi M, Sweeney E, Wall E, Jahl P, Bell R Cell Metab. 2022; 34(11):1779-1791.e9.

PMID: 36240759 PMC: 9633563. DOI: 10.1016/j.cmet.2022.09.001.


The Effects of Major Mushroom Bioactive Compounds on Mechanisms That Control Blood Glucose Level.

Aramabasic Jovanovic J, Mihailovic M, Uskokovic A, Grdovic N, Dinic S, Vidakovic M J Fungi (Basel). 2021; 7(1).

PMID: 33467194 PMC: 7830770. DOI: 10.3390/jof7010058.


Native Zinc Catalyzes Selective and Traceless Release of Small Molecules in β-Cells.

Lee M, Maji B, Manna D, Kahraman S, Elgamal R, Small J J Am Chem Soc. 2020; 142(14):6477-6482.

PMID: 32175731 PMC: 7146867. DOI: 10.1021/jacs.0c00099.


Inhibition of DYRK1A Stimulates Human β-Cell Proliferation.

Dirice E, Walpita D, Vetere A, Meier B, Kahraman S, Hu J Diabetes. 2016; 65(6):1660-71.

PMID: 26953159 PMC: 4878416. DOI: 10.2337/db15-1127.


References
1.
Keenan H, Sun J, Levine J, Doria A, Aiello L, Eisenbarth G . Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes. 2010; 59(11):2846-53. PMC: 2963543. DOI: 10.2337/db10-0676. View

2.
Bork P, Sander C, Valencia A . Convergent evolution of similar enzymatic function on different protein folds: the hexokinase, ribokinase, and galactokinase families of sugar kinases. Protein Sci. 1993; 2(1):31-40. PMC: 2142297. DOI: 10.1002/pro.5560020104. View

3.
Juang J, Kuo C, Wu C, Juang C . Exendin-4 treatment expands graft beta-cell mass in diabetic mice transplanted with a marginal number of fresh islets. Cell Transplant. 2008; 17(6):641-7. DOI: 10.3727/096368908786092766. View

4.
Andres C, Fox I . Purification and properties of human placental adenosine kinase. J Biol Chem. 1979; 254(22):11388-93. View

5.
Grembecka J, He S, Shi A, Purohit T, Muntean A, Sorenson R . Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia. Nat Chem Biol. 2012; 8(3):277-84. PMC: 3401603. DOI: 10.1038/nchembio.773. View